tiprankstipranks
Trending News
More News >
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
US Market
Advertisement

Barinthus Biotherapeutics (BRNS) Financial Statements

Compare
101 Followers

Barinthus Biotherapeutics Financial Overview

Barinthus Biotherapeutics's market cap is currently $58.32M. The company's EPS TTM is $-0.52; its P/E ratio is ―; Barinthus Biotherapeutics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Barinthus Biotherapeutics Earnings and Revenue History

Barinthus Biotherapeutics Debt to Assets

Barinthus Biotherapeutics Cash Flow

Barinthus Biotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis